Sab Biotherapeutics Inc SABS

$2.98 -0.08 (-2.61%)

Valuation

Market cap
278,417,000
Revenue TTM
$0
Net income TTM
$13,270,000
PE ratio
0.00
Forward PE
—
Profit margin
0.00%
Debt to equity
0.00

Trading

Volume
416,300
Avg volume
475,624
Day's range
$2.96 – $3.12
Shares out
90,986,000
Stochastic %K
3%
Beta
0.58
Analysts
Strong Sell
Price target
$11.82

Price

Company profile

SAB Biotherapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of human polyclonal immunotherapeutic antibodies to address immune system disorders and infectious diseases in the United States. Its lead product candidate is SAB-142, a potentially disease-modifying and redosable immunotherapy in clinical development for the treatment of autoimmune type 1 diabetes in Phase 2b clinical...

Show more

SAB Biotherapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of human polyclonal immunotherapeutic antibodies to address immune system disorders and infectious diseases in the United States. Its lead product candidate is SAB-142, a potentially disease-modifying and redosable immunotherapy in clinical development for the treatment of autoimmune type 1 diabetes in Phase 2b clinical trials. The company was founded in 2014 and is headquartered in Miami Beach, Florida.

Industry
Biotechnology
Sector
Healthcare
Phone
305 845 2813
Website
https://www.sab.bio
Address
777 W 41st St., Miami Beach, United States

Latest news

Stocktwits

Wences Oct 1, 8:10 AM
$SABS going to $1.75. Enrollment warrants exercise.
2 replies
Marcink83 Sep 30, 2:52 PM
$SABS
0 replies
Marcink83 Sep 30, 2:24 PM
$SABS SAB BIO is presenting SAB-142 data today, September 30, at the EASD meeting in Milan. The presentations cover mechanism of action, C-peptide response, safe redosing/non-immunogenicity, and early efficacy signals in Type 1 diabetes.
1 replies
JTebow_CWS Sep 30, 2:41 AM
$SABS Excellent podcast. https://integrateddiabetesservices.podbean.com/e/can-you-keep-your-honeymoon-going-sab-bio-clinical-trial-for-newly-diagnosed-t1d/
0 replies
Nicks_pics Sep 30, 2:05 AM
$SABS team is spreading the word. Carry on. https://x.com/sabbantibody/status/2105009527238090993?s=12
0 replies
a36er Sep 29, 2:16 PM
$SABS Volume
0 replies
Marcink83 Sep 28, 2:39 PM
$SABS I like the risk/reward after the recent pullback. SAB-142 continues progressing, fresh data is being presented at EASD, and the company has runway through 2028. Interesting setup at these levels — let’s see if buyers step in. 👀🚀
1 replies
Marcink83 Sep 28, 2:08 PM
$SABS in. Swing
0 replies